Literature DB >> 2118234

Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma.

N Sarvetnick1, J Shizuru, D Liggitt, L Martin, B McIntyre, A Gregory, T Parslow, T Stewart.   

Abstract

Interferon-gamma (IFN-gamma) is produced during the response to infection and participates in immunostimulatory events. We have previously reported the induction of diabetes in transgenic mice (ins-IFN-gamma) in which the expression of the lymphokine IFN-gamma is directed by the insulin promoter. This diabetes is a result of the progressive destruction of pancreatic islets that occurs with the influx of inflammatory cells. Here we demonstrate that this islet cell loss is mediated by lymphocytes, that engrafted histocompatible islets are destroyed, and that lymphocytes from the transgenic mice are cytotoxic to normal islets in vitro. These results indicate that the pancreatic expression of IFN-gamma can result in a loss of tolerance to normal islets, consistent with its role as an inducer of costimulatory activity, which is essential for lymphocyte activation during an immune response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118234     DOI: 10.1038/346844a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  78 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.

Authors:  J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

3.  T cell-independent rescue of B lymphocytes from peripheral immune tolerance.

Authors:  V Kouskoff; G Lacaud; D Nemazee
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

Review 4.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 5.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease.

Authors:  A al-Dawoud; I Nakshabendi; A Foulis; A M Mowat
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

Review 7.  Autoimmune diabetes and the germ theory of disease.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

Review 8.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

9.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice.

Authors:  I L Campbell; M V Hobbs; J Dockter; M B Oldstone; J Allison
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.